CfDNA in the plasma has a high specificity in detecting EGFR mutations but is associated with a low sensitivity; this is because very small amounts of cfDNA exist in the blood as cfDNA is released from tumor cells only during cell death and is rapidly cleared from the circulation [9]. The gene discussed is EGFR; the disease is neoplasm.